5,661 research outputs found
Historia von D. Johann Fausten, Text des Drucks von 1587, mit den Zusatztexten der Wolfenbütteler Handschrift und der zeitgenössischen Drucke, hrsg. von Stephan Füssel und Hans Joachim Kreutzer : Krit. Ausg., Stuttgart, Reclam, 1988 / [rezensiert von:] Frank Baro
No full textHISTORIA VON D. JOHANN FAUSTEN, TEXT DES DRUCKS VON 1587, MIT DEN ZUSATZTEXTEN DER WOLFENBÜTTELER HANDSCHRIFT UND DER ZEITGENÖSSISCHEN DRUCKE, HRSG. VON STEPHAN FÜSSEL UND HANS JOACHIM KREUTZER : KRIT. AUSG., STUTTGART, RECLAM, 1988 / [REZENSIERT VON:] FRANK BARO
Historia von D. Johann Fausten, Text des Drucks von 1587, mit den Zusatztexten der Wolfenbütteler Handschrift und der zeitgenössischen Drucke, hrsg. von Stephan Füssel und Hans Joachim Kreutzer : Krit. Ausg., Stuttgart, Reclam, 1988 / [rezensiert von:] Frank Baro (1)
Cover (1)
Rezension: Historia von D. Johann Fausten, Text des Drucks von 1587 (3
St. Stephan in Mainz
No full texthttp://www.dilibri.de/rlb/content/structure/296109 1000 Jahre St. Stephan in Mainz : Festschrift / hrsg. von Helmut Hinkel Mainz : Verl. der Ges. für Mittelrheinische Kirchengeschichte, 1990 Werner Goez: Leben und Werk des heiligen Willigis PDF 33Franz Staab: Eine Metzer Miniatur des heiligen Willigis aus dem 12. Jahrhundert PDF 47Isnard W. Frank: Sancta Sedes Maguntina. Willigis und der "Heilige Stuhl von Mainz" PDF 59Franz Staab: Reich und Mittelrhein um 1000 PDF 101Gerhard Ludwig Müller: D..
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2021
No full textAbstract The Journal of Cachexia, Sarcopenia and Muscle (JCSM) aims to publish articles with relevance to wasting disorders and illnesses of the muscle in the broadest sense. In order to avoid publication of inappropriate articles and to avoid protracted disputes, the Editors have established ethical guidelines that detail a number of regulations to be fulfilled prior to submission to the journal. This article updates the principles of ethical authorship and publishing in JCSM and its two daughter journals JCSM Rapid Communication and JCSM Clinical Reports. We require the corresponding author, on behalf of all co‐authors, to certify adherence to the following principles: All authors listed on a manuscript considered for publication have approved its submission and (if accepted) approve publication in the journal; Each named author has made a material and independent contribution to the work submitted for publication; No person who has a right to be recognized as author has been omitted from the list of authors on the submitted manuscript; The submitted work is original and is neither under consideration elsewhere nor that it has been published previously in whole or in part other than in abstract form; All authors certify that the submitted work is original and does not contain excessive overlap with prior or contemporaneous publication elsewhere, and where the publication reports on cohorts, trials, or data that have been reported on before the facts need to be acknowledged and these other publications must be referenced; All original research work has been approved by the relevant bodies such as institutional review boards or ethics committees; All relevant conflicts of interest, financial or otherwise, that may affect the authors' ability to present data objectively, and relevant sources of funding of the research in question have been duly declared in the manuscript; All authors certify that they will submit the original source data to the editorial office upon request; The manuscript in its published form will be maintained on the servers of the journal as a valid publication only as long as all statements in these guidelines remain true; If any of the aforementioned statements ceases to be true, the authors have a duty to notify as soon as possible the Editor‐in‐Chief of the journal, so that the available information regarding the published article can be updated and/or the manuscript can be withdrawn
Figure 2 in In Memoriam: Michael C. Thomas
No full textFigure 2. Mike Thomas art from Stephan (1989), a–c) Bothrideridae and d–j) Zopheridae (Colydiinae). a) Lithophorus ornatus Arrow. b) Prolyctus exaratus (Melsheimer). c) Oxylaemus americanus LeConte. d) Bitoma quadriguttata (Say). e) Aulonium parallelopipedum (Say). f) Nematidium filiforme LeConte. g) Coxelus serratus Horn. h) Denophloeus nosodermoides (Horn). i) Eudesma undulata (Melsheimer). j) Rhagodera costata Horn.Published as part of Skelley, Paul E. & Frank, J. Howard, 2020, In Memoriam: Michael C. Thomas, pp. 1-32 in Insecta Mundi 2020 (829) on page 3, DOI: 10.5281/zenodo.535375
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: Update 2023
No full textAbstract The Journal of Cachexia, Sarcopenia and Muscle (JCSM) aims to publish articles with relevance to wasting disorders and illnesses of the muscle in the broadest sense. In order to avoid publication of inappropriate articles and to avoid protracted disputes, the Editors have established ethical guidelines that detail a number of regulations to be fulfilled prior to submission to the journal. This article updates the principles of ethical authorship and publishing in JCSM and its daughter journal JCSM Rapid Communication. We require the corresponding author, on behalf of all co‐authors, to certify adherence to the following principles: All authors listed on a manuscript considered for publication have approved its submission and (if accepted) approve publication in the journal; Each named author has made a material and independent contribution to the work submitted for publication. No person who has a right to be recognized as author has been omitted from the list of authors on the submitted manuscript; The submitted work is original and is neither under consideration elsewhere nor that it has been published previously in whole or in part other than in abstract form; All authors certify that the submitted work is original and does not contain excessive overlap with prior or contemporaneous publication elsewhere, and where the publication reports on cohorts, trials, or data that have been reported on before the facts need to be acknowledged and these other publications must be referenced; All original research work has been approved by the relevant bodies such as institutional review boards or ethics committees; All relevant conflicts of interest, financial or otherwise, that may affect the authors' ability to present data objectively, and relevant sources of funding of the research in question have been duly declared in the manuscript; All authors certify that they will submit the original source data to the editorial office upon request; Authors who have used artificial intelligence, language models, machine learning, or similar technologies need to provide a written statement – as part of the manuscript – that details the use of the respective technology; none of the aforementioned technologies can be listed as an author; The manuscript in its published form will be maintained on the servers of the journal as a valid publication only as long as all statements in these guidelines remain true. If any of the aforementioned statements ceases to be true, the authors have a duty to notify as soon as possible the Editor‐in‐Chief of the journal, so that the available information regarding the published article can be updated and/or the manuscript can be withdrawn
TRA8/05 Variations on U-shaped Learning
No full texttutorial article, which has been submitted for publication in a journal or for consideration by the commissioning organization. The report represents the ideas of its author, and should not be taken as the official views of the School or the University. Any discussion of the content of the report should be sent to the author, at the address shown on the cover. JAFFAR, Joxa
: update 2019
No full textAbstract This article details an updated version of the principles of ethical authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle (JCSM) and its two daughter journals JCSM Rapid Communication and JCSM Clinical Reports. We request of all author sending to the journal a paper for consideration that at the time of submission to JCSM, the corresponding author, on behalf of all co‐authors, needs to certify adherence to these principles. The principles are as follows: all authors listed on a manuscript considered for publication have approved its submission and (if accepted) approve publication in JCSM as provided; each named author has made a material and independent contribution to the work submitted for publication; no person who has a right to be recognized as author has been omitted from the list of authors on the submitted manuscript; the submitted work is original and is neither under consideration elsewhere nor that it has been published previously in whole or in part other than in abstract form; all authors certify that the submitted work is original and does not contain excessive overlap with prior or contemporaneous publication elsewhere, and where the publication reports on cohorts, trials, or data that have been reported on before the facts need to be acknowledged and these other publications must be referenced; all original research work has been approved by the relevant bodies such as institutional review boards or ethics committees; all relevant conflicts of interest, financial or otherwise, that may affect the authors' ability to present data objectively, and relevant sources of funding of the research in question have been duly declared in the manuscript; the manuscript in its published form will be maintained on the servers of JCSM as a valid publication only as long as all statements in the guidelines on ethical publishing remain true. If any of the aforementioned statements ceases to be true, the authors have a duty to notify as soon as possible the Editors of JCSM, JCSM Rapid Communication, and JCSM Clinical Reports, respectively, so that the available information regarding the published article can be updated and/or the manuscript can be withdrawn
Catalytic P-H activation by Ti and Zr catalysts
No full textCatalytic dehydrocoupling of phosphines was investigated using the anionic zirconocene trihydride salts [Cp*Zr-2(mu-H)(3)Li](3) (1a) or [Cp*Zr-2(mu-H)(3)K(thf)(4)] (1b), and the metallocycles [CpTi(NPtBu3)(CH2)(4)] (6) and [Cp*M(NPtBu3)(CH2)(4)] (M = Ti 20, Zr 21) as catalyst precursors. Dehydrocoupling of primary phosphines RPH2 (R = Ph, C6H2Me3, Cy, C10H7) gave both dehydrocoupled dimers RP(H)P(H)R or cyclic oligophosphines (RP)(n) (n = 4, 5) while reaction of tBu(3)C(6)H(2)PH(2) gave the phosphaindoline tBu(2)(Me2CCH2)C6H2PH (9). Stoichiometric reactions of these catalyst precursors with primary phosphines afforded [Cp*Zr-2((PR)(2))H][K(thf)(4)] (R = Ph 2, Cy 3, C6H2Me3 4), [Cp*Zr-2((PPh)(3))H] [K(thf)(4)] (5), [CpTi(NPtBu3)(PPh)(3)] (7) and [CpTi(NPtBu3)(mu-PHPh)](2) (8), while reaction of 6 with (C(6)H(2)tBu3)PH2 in the presence of PMe3 afforded [CpTi(NPtBu3)(PMe3)(p(C(6)H(2)tBu(3))] (10). The secondary phosphines Ph2PH and (PhHPCH2)(2)CH2 also undergo dehydrocoupling affording (Ph2P)(2) and (PhPCH2)(2)CH2. The bisphosphines (CH2PH2)(2) and C6H4(PH2)(2) are dehydrocoupled to give (PCH2CH2PH)(2) (12) and (C6H4P(PH))(2) (13) while prolonged reaction of 13 gave (C6H4P2)(8) (14). The analogous bisphosphine Me2C6H4(PH)(2) (17) was prepared and dehydrocoupling catalysis afforded (Me2C6H2P(PH))(2) (18) and subsequently [(Me2C6H2P2)(2)(mu-Me2C6H2P2)](2) (19). Stoichiometric reactions with these bisphosphines gave [Cp*Zr-2(H)(PH)(2)C6H4] [Li(thf)(4)] (22), [Cp*Ti(NPtBu3)(PH)(2)C6H4](2) (23) and [Cp*Ti(NPtBu3)(PH)(2)C6H4] (24). Mechanistic implications are discussed.PT: J; CR: ALBRAND JP, 1976, J CHEM SOC CHEM COMM, P876 ANSELME JP, 1969, TETRAHEDRON, V25, P855 BASULI F, 2003, J AM CHEM SOC, V125, P10170 BAUDLER M, 1976, Z NATURFORSCH B, V31, P558 BAUDLER M, 1978, CHEM BER, V111, P1210 BAUDLER M, 1978, CHEM BER, V111, P1217 BAUDLER M, 1983, CHEM BER, V116, P2711 BAUDLER M, 1984, Z NATURFORSCH B, V39, P438 BAZAN GC, 1991, J AM CHEM SOC, V113, P6899 BOHM VPW, 2001, ANGEW CHEM, V113, P4832 CHAUVIN Y, 1971, MAKROMOL CHEM, V141, P161 COREY JY, 2004, ADV ORGANOMET CHEM, V51, P1 COURET C, 1986, ORGANOMETALLICS, V5, P113 COWLEY AH, 1984, TETRAHEDRON LETT, V25, P2125 COWLEY AH, 1990, INORG SYNTH, V27, P235 CROMER DT, 1974, INT TABLES CRYSTALLO, V4, P71 ETKIN N, 1997, J AM CHEM SOC, V119, P11420 ETKIN N, 1997, J AM CHEM SOC, V119, P2954 ETKIN N, 1997, ORGANOMETALLICS, V16, P3504 FEHLNER TP, 1992, INORGANOMETALLLICS FERMIN MC, 1995, J AM CHEM SOC, V117, P12645 FERMIN MC, 1995, ORGANOMETALLICS, V14, P4247 FU GC, 1993, J AM CHEM SOC, V115, P9856 GAUVIN F, 1998, ADV ORGANOMET CHEM, V42, P363 GRAHAM TW, 2004, ORGANOMETALLICS, V23, P3309 GRUBBS RH, 1972, J AM CHEM SOC, V94, P2538 GRUBBS RH, 2003, HDB METATHESIS HEY E, 1988, CHEM BER, V121, P561 HEY E, 1989, J ORGANOMET CHEM, V378, P375 HO JW, 1991, ORGANOMETALLICS, V10, P3001 HO JW, 1994, INORG CHEM, V33, P865 HOFFMAN PR, 1975, INORG CHEM, V14, P1997 HOSKIN AJ, 2001, ANGEW CHEM, V113, P1917 HOU ZM, 1993, ORGANOMETALLICS, V12, P3158 INAGAKI Y, 1980, B CHEM SOC JPN, V53, P205 ISSLEIB K, 1972, ANGEW CHEM, V84, P582 ISSLEIB K, 1987, J ORGANOMET CHEM, V330, P17 JACOBSEN EN, 1988, J AM CHEM SOC, V110, P1968 KATSUKI T, 1980, J AM CHEM SOC, V102, P5974 KAUFFMANN T, 1984, TETRAHEDRON LETT, V25, P1963 KAUFFMANN T, 1985, CHEM BER, V118, P1022 KITAMURA M, 1988, J AM CHEM SOC, V110, P629 KNOWLES WS, 1983, ACCOUNTS CHEM RES, V16, P106 KOEPF H, 1981, CHEM BER, V114, P2731 KOHLER EP, 1935, J AM CHEM SOC, V57, P367 KYBA EP, 1983, ORGANOMETALLICS, V2, P1877 MILLER AR, 1976, J AM CHEM SOC, V98, P1860 MILLER SJ, 1996, J AM CHEM SOC, V118, P9606 MIYASHITA A, 1980, J AM CHEM SOC, V102, P7932 MURDZEK JS, 1987, ORGANOMETALLICS, V6, P1373 NGUYEN ST, 1992, J AM CHEM SOC, V114, P3974 NGUYEN ST, 1993, J AM CHEM SOC, V115, P9858 NOVAK BM, 1988, J AM CHEM SOC, V110, P960 OHKUMA T, 1995, J AM CHEM SOC, V117, P2675 OHTA T, 1988, INORG CHEM, V27, P566 OSHIKAWA T, 1985, CHEM IND-LONDON, P126 ROCKLAGE SM, 1981, J AM CHEM SOC, V103, P1440 SCHOLL M, 1999, TETRAHEDRON LETT, V40, P2247 SCHROCK RR, 1974, J AM CHEM SOC, V96, P6796 SCHROCK RR, 1980, J MOL CATAL, V8, P73 SCHROCK RR, 1988, J MOL CATAL, V46, P243 SCHROCK RR, 1990, J AM CHEM SOC, V112, P3875 SCHWAB P, 1995, ANGEW CHEM INT EDIT, V34, P2039 SCHWAB P, 1995, ANGEW CHEM, V107, P2179 SCHWAB P, 1996, J AM CHEM SOC, V118, P100 SENDERIKHIN AI, 1988, ZH OBSHCH KHIM+, V58, P1662 SENDERIKHIN AI, 1989, ZH OBSHCH KHIM+, V59, P2141 SEYFERTH D, 1969, J ORG CHEM, V34, P1483 SHELDRICK GM, 2000, SHELXTL SHU RH, 1998, J AM CHEM SOC, V120, P12988 SMIT CN, 1983, TETRAHEDRON LETT, V24, P2031 SOUFFLET JP, 1973, CR ACAD SCI C CHIM, V276, P169 STEPHAN DW, 2000, ANGEW CHEM, V112, P322 STEPHAN DW, 2005, ORGANOMETALLICS, V24, P2548 STRADIOTTO M, 2001, HELV CHIM ACTA, V84, P2958 TILLEY TD, 1990, COMMENTS INORG CHEM, V10, P37 TILLEY TD, 1993, ACCOUNTS CHEM RES, V26, P22 TVERDOMED SN, 2003, RUSS J GEN CHEM+, V73, P319 VANDENWINKEL Y, 1991, J ORGANOMET CHEM, V405, P183 WATERMAN R, 2006, ANGEW CHEM INT EDIT, V45, P2926 WATERMAN R, 2006, ANGEW CHEM, V118, P2992 WEAST RC, 1974, HDB CHEM PHYS, P2436 WOOD CD, 1979, J AM CHEM SOC, V101, P3210 WU Z, 1995, J AM CHEM SOC, V117, P5503 XIN SX, 1997, J AM CHEM SOC, V119, P5307; NR: 85; TC: 0; J9: CHEM-EUR J; PG: 12; GA: 113PJSource type: Electronic(1
- …
